| Oct 25 |
Highbridge Capital Management's Strategic Acquisition of Fortress Biotech Shares
|
| Oct 25 |
Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
|
| Oct 24 |
Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
|
| Oct 9 |
Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit
|
| Oct 3 |
Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
|
| Sep 20 |
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements
|
| Sep 9 |
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
|
| Sep 4 |
Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
| Sep 4 |
Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
| Sep 4 |
Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
|
